Katsushima Utae, Fukushima Takuya, Nakano Jiro, Ogushi Naoya, Fujii Kazuki, Nagata Yutaro, Kamisako Keisuke, Okuno Yukiko, Okazaki Yuta, Nakanishi Kentaro, Yoshida Kiyori, Ikoma Tatsuki, Takeyasu Yuki, Yamanaka Yuta, Yoshioka Hiroshige, Hase Kimitaka, Kurata Takayasu
Department of Thoracic Oncology, Kansai Medical University, Osaka, Japan.
Faculty of Rehabilitation, Kansai Medical University, Osaka, Japan.
Thorac Cancer. 2025 Jan;16(2):e15503. doi: 10.1111/1759-7714.15503. Epub 2024 Dec 9.
Cachexia is a poor prognostic factor in many advanced cancers. Cachexia diagnostic criteria of the European Palliative Care Research Collaboration (EPCRC) may underestimate cachexia in Asians; therefore, new criteria have been proposed by the Asian Working Group for Cachexia (AWGC). We compared both criteria to determine differences in diagnostic rates and their association with lung cancer prognosis.
This single-center, retrospective cohort study considered lung cancer outpatients receiving chemotherapy. Survival was analyzed using Kaplan-Meier curves and log-rank tests. The association between cachexia diagnosis and prognosis was examined for each set of criteria using a Cox proportional hazards model. C-statistic analysis was performed to compare the discriminative power for prognosis.
Among the 106 participants analyzed (median age, 75 [71-79] years; 75 males [70.8%]; 91 [85.9%] with performance status [PS] 0-1), 58 (54.7%) and 77 (72.6%) cachexia cases were diagnosed using the EPCRC and AWGC criteria, respectively. The latter encompassed all but one patient diagnosed using the EPCRC criteria. Patients with cachexia had a significantly poorer prognosis according to both criteria (EPCRC, p = 0.002; AWGC, p = 0.001). Both criteria had almost equal discriminative power for prognosis (EPCRC, C-statistic = 0.658; AWGC, C-statistic = 0.658). CRP in the AWGC criteria was most strongly related to prognosis.
Cachexia was an independent poor prognostic factor in lung cancer patients receiving chemotherapy under the AWGC and EPCRC criteria, both of which had similar prognostic discriminatory power. Among CRP, anorexia, and grip strength, elevated CRP may be the most prognostically relevant parameter in the AWGC criteria.
恶病质是许多晚期癌症患者预后不良的因素。欧洲姑息治疗研究协作组(EPCRC)的恶病质诊断标准可能会低估亚洲人的恶病质情况;因此,亚洲恶病质工作组(AWGC)提出了新的标准。我们比较了这两种标准,以确定诊断率的差异及其与肺癌预后的关联。
这项单中心回顾性队列研究纳入了接受化疗的肺癌门诊患者。采用Kaplan-Meier曲线和对数秩检验分析生存率。使用Cox比例风险模型检查每组标准下恶病质诊断与预后之间的关联。进行C统计分析以比较预后判别能力。
在分析的106名参与者中(中位年龄75[71-79]岁;75名男性[70.8%];91名[85.9%]的体能状态[PS]为0-1),分别使用EPCRC和AWGC标准诊断出58例(54.7%)和77例(72.6%)恶病质病例。后者涵盖了除1例使用EPCRC标准诊断的患者外的所有患者。根据这两种标准,恶病质患者的预后均明显较差(EPCRC,p = 0.002;AWGC,p = 0.001)。两种标准对预后的判别能力几乎相同(EPCRC,C统计量= 0.658;AWGC,C统计量= 0.658)。AWGC标准中的CRP与预后的相关性最强。
根据AWGC和EPCRC标准,恶病质是接受化疗的肺癌患者独立的预后不良因素,二者具有相似的预后判别能力。在CRP、厌食和握力中,CRP升高可能是AWGC标准中最具预后相关性的参数。